Works by Kaya, Daisuke


Results: 20
    1
    2

    Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening Endoscopy.

    Published in:
    Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3510, doi. 10.3390/jcm9113510
    By:
    • Ishida, Koji;
    • Namisaki, Tadashi;
    • Murata, Koji;
    • Fujimoto, Yuki;
    • Takeda, Souichi;
    • Enomoto, Masahide;
    • Ogawa, Hiroyuki;
    • Takagi, Hirotetsu;
    • Tsuji, Yuki;
    • Kaya, Daisuke;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Sawada, Yasuhiko;
    • Kitagawa, Kou;
    • Sato, Shinya;
    • Nishimura, Norihisa;
    • Takaya, Hiroaki;
    • Kaji, Kosuke;
    • Shimozato, Naotaka;
    • Kawaratani, Hideto
    Publication type:
    Article
    3
    4
    5
    6
    7

    Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver disease.

    Published in:
    JGH Open, 2020, v. 4, n. 3, p. 400, doi. 10.1002/jgh3.12264
    By:
    • Tahara, Kazuki;
    • Akahane, Takemi;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Kawaratani, Hideto;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Shimozato, Naotaka;
    • Sato, Shinya;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Kubo, Takuya;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Kitagawa, Koh;
    • Ozutsumi, Takahiro;
    • Tsuji, Yuuki;
    • Kaya, Daisuke;
    • Ogawa, Hiroyuki
    Publication type:
    Article
    8

    Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients.

    Published in:
    Antibiotics (2079-6382), 2020, v. 9, n. 4, p. 145, doi. 10.3390/antibiotics9040145
    By:
    • Kaji, Kosuke;
    • Saikawa, Soichiro;
    • Takaya, Hiroaki;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Kitagawa, Koh;
    • Ozutsumi, Takahiro;
    • Kaya, Daisuke;
    • Tsuji, Yuki;
    • Sawada, Yasuhiko;
    • Kawaratani, Hideto;
    • Moriya, Kei;
    • Namisaki, Tadashi;
    • Akahane, Takemi;
    • Mitoro, Akira;
    • Yoshiji, Hitoshi;
    • Leitão, Jorge H.
    Publication type:
    Article
    9

    Association between Equol Production Status and Nonalcoholic Steatohepatitis.

    Published in:
    International Journal of Molecular Sciences, 2021, v. 22, n. 21, p. 11904, doi. 10.3390/ijms222111904
    By:
    • Akahane, Takemi;
    • Kaya, Daisuke;
    • Noguchi, Ryuichi;
    • Kaji, Kosuke;
    • Miyakawa, Haruna;
    • Fujinaga, Yukihisa;
    • Tsuji, Yuki;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Furukawa, Masanori;
    • Kitagawa, Koh;
    • Ozutsumi, Takahiro;
    • Kawaratani, Hideto;
    • Moriya, Kei;
    • Namisaki, Tadashi;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    10

    Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis.

    Published in:
    International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5589, doi. 10.3390/ijms21155589
    By:
    • Fujinaga, Yukihisa;
    • Kawaratani, Hideto;
    • Kaya, Daisuke;
    • Tsuji, Yuki;
    • Ozutsumi, Takahiro;
    • Furukawa, Masanori;
    • Kitagawa, Koh;
    • Sato, Shinya;
    • Nishimura, Norihisa;
    • Sawada, Yasuhiko;
    • Takaya, Hiroaki;
    • Kaji, Kosuke;
    • Shimozato, Naotaka;
    • Moriya, Kei;
    • Namisaki, Tadashi;
    • Akahane, Takemi;
    • Mitoro, Akira;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    11

    Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.

    Published in:
    International Journal of Molecular Sciences, 2020, v. 21, n. 6, p. 2164, doi. 10.3390/ijms21062164
    By:
    • Ozutsumi, Takahiro;
    • Namisaki, Tadashi;
    • Shimozato, Naotaka;
    • Kaji, Kosuke;
    • Tsuji, Yuki;
    • Kaya, Daisuke;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Nakanishi, Keisuke;
    • Sato, Shinya;
    • Sawada, Yasuhiko;
    • Saikawa, Soichiro;
    • Kitagawa, Koh;
    • Takaya, Hiroaki;
    • Kawaratani, Hideto;
    • Kitade, Mitsuteru;
    • Moriya, Kei;
    • Noguchi, Ryuichi;
    • Akahane, Takemi;
    • Mitoro, Akira
    Publication type:
    Article
    12

    Ancylostoma ceylanicum, novel etiological agent for traveler's diarrhea--report of four Japanese patients who returned from Southeast Asia and Papua New Guinea.

    Published in:
    Tropical Medicine & Health, 2018, v. 46, n. 1, p. 1, doi. 10.1186/s41182-018-0087-8
    By:
    • Masahide Yoshikawa;
    • Yukiteru Ouji;
    • Nobuyasu Hirai;
    • Fukumi Nakamura-Uchiyama;
    • Minoru Yamada;
    • Naoki Arizono;
    • Naoaki Akamatsu;
    • Takaharu Yoh;
    • Daisuke Kaya;
    • Toshiya Nakatani;
    • Eiryo Kikuchi;
    • Yuichi Katanami;
    • Kimitoshi Satoh;
    • Ryosuke Maki;
    • Yusuke Miyazato;
    • Yuichiro Oba;
    • Kei Kasahara;
    • Keiichi Mikasa
    Publication type:
    Article
    13
    14

    Chronic Alcohol Consumption is Inversely Associated with Insulin Resistance and Fatty Liver in Japanese Males.

    Published in:
    Nutrients, 2020, v. 12, n. 4, p. 1036, doi. 10.3390/nu12041036
    By:
    • Akahane, Takemi;
    • Namisaki, Tadashi;
    • Kaji, Kosuke;
    • Moriya, Kei;
    • Kawaratani, Hideto;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Shimozato, Naotaka;
    • Fujinaga, Yukihisa;
    • Furukawa, Masanori;
    • Kitagawa, Koh;
    • Ozutsumi, Takahiro;
    • Tsuji, Yuuki;
    • Kaya, Daisuke;
    • Ogawa, Hiroyuki;
    • Takagi, Hirotetsu;
    • Ishida, Koji;
    • Yoshiji, Hitoshi
    Publication type:
    Article
    15
    16

    Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase‐4 inhibitor on hepatic fibrosis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 10, p. 1147, doi. 10.1111/hepr.13385
    By:
    • Shimozato, Naotaka;
    • Namisaki, Tadashi;
    • Kaji, Kosuke;
    • Kitade, Mitsuteru;
    • Okura, Yasushi;
    • Sato, Shinya;
    • Moriya, Kei;
    • Seki, Kenichiro;
    • Kawaratani, Hideto;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Fujinaga, Yukihisa;
    • Kubo, Takuya;
    • Asada, Kiyoshi;
    • Kitagawa, Koh;
    • Tsuji, Yuki;
    • Kaya, Daisuke
    Publication type:
    Article
    17

    Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 2, p. 232, doi. 10.1111/hepr.13249
    By:
    • Okura, Yasushi;
    • Namisaki, Tadashi;
    • Sato, Shinya;
    • Moriya, Kei;
    • Akahane, Takemi;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Shimozato, Naotaka;
    • Seki, Kenichiro;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Fujinaga, Yukihisa;
    • Kubo, Takuya;
    • Kaya, Daisuke;
    • Tsuji, Yuki;
    • Ozutsumi, Takahiro
    Publication type:
    Article
    18
    19
    20